Lipoprotein Lipase (LPL) (C-Term) Peptide
Aperçu rapide pour Lipoprotein Lipase (LPL) (C-Term) Peptide (ABIN979546)
Antigène
Origine
Source
Application
-
-
Protein Region
- C-Term
-
Séquence
- LGYEINKVRA KRSSKMYLKT RSQMPYKVFH YQVKIHFSGT ESETHTNQAF
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LPL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Lipoprotein Lipase (LPL)
-
Sujet
-
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alias Symbols: HDLCQ11, LIPD
Protein Interaction Partner: APOC2,ASCC2,CALR,CETP,COPS6,KIAA1377,LPL,LRP1,LRP2,LUC7L2,PTPN4,RPL18A,UBE2Z,VLDLR,ASCC2,COPS6,EMD,KIAA1377,LRP1,LRP2,LUC7L2,PLK1,PTPN4,RPL18A,UBE2Z,VLDLR
Protein Size: 475 -
Poids moléculaire
- 50 kDa
-
ID gène
- 4023
-
NCBI Accession
- NM_000237, NP_000228
-
UniProt
- P06858
Antigène
-